Cancer Research UK logo.
SearchDonate
  • Search

A trial of stereotactic body radiotherapy with targeted drug treatment in advanced non small lung cancer (HALT)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers

Status:

Closed

Phase:

Phase 2/3

Details

This trial is for people with advanced non small cell lung cancer that can’t be treated with the aim to cure. And who:

  • have certain changes (mutations) in their lung cancer cells

  • are having a targeted cancer drug

  • have 5 or fewer areas of cancer that have now stopped responding to targeted cancer treatment

Cancer Research UK supports this trial.

Recruitment start: 27 November 2017

Recruitment end: 17 July 2023

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Fiona McDonald

Supported by

Cancer Research UK

European Organisation for Research and Treatment of Cancer (EORTC)

ICR Clinical Trials and Statistics Unit (ICR-CTSU)

NHS England

Radiotherapy Trials Quality Assurance (RTTQA)

Other information

This is Cancer Research UK trial number CRUK/16/020.

Last reviewed: 18 July 2023

CRUK internal database number: 15118

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.